Larimar Therapeutics (LRMR) Return on Assets [ROA] (2014 - 2026)
Larimar Therapeutics (LRMR) recorded Return on Assets [ROA] of -112.91% in Q2 2026, down 45.11 percentage points from -67.80% a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Larimar Therapeutics reported Return on Assets [ROA] of -99.69%, down 38.31 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -21.78 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -61.38% in FY2024 (-23.82 pp), -37.56% in FY2023 (-1.94 pp), -35.62% in FY2022 (+19.42 pp) and -55.05% in FY2021 (+22.86 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] in data going back to Q3 2014.
- On a year-over-year basis, Return on Assets [ROA] rose in 1 of the last seven quarters, with an average year-over-year change of -31.78 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 34.28 percentage points in Q1 2023, against a drop of 60.18 percentage points in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Larimar Therapeutics | 279.45 Mn | -389.49 Mn | - | -92.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -92.35% |
| Mar 31, 2026 | -93.72% |
| Dec 31, 2025 | -99.50% |
| Sep 30, 2025 | -78.43% |
| Jun 30, 2025 | -62.25% |
| Mar 31, 2025 | -51.38% |
| Dec 31, 2024 | -38.42% |
| Sep 30, 2024 | -28.24% |
| Jun 30, 2024 | -24.11% |
| Mar 31, 2024 | -26.21% |
| Dec 31, 2023 | -36.86% |
| Sep 30, 2023 | -30.91% |
| Jun 30, 2023 | -28.24% |
| Mar 31, 2023 | -26.85% |
| Dec 31, 2022 | -27.28% |
| Sep 30, 2022 | -35.84% |
| Jun 30, 2022 | -65.05% |
| Mar 31, 2022 | -63.37% |
| Dec 31, 2021 | -60.79% |
| Sep 30, 2021 | -65.97% |
API Access
Larimar Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();